Markets:

Overview

News

Currencies

International

Treasuries

Bristol-Myers Squibb (NY:BMY)

48.25 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

83 84 Next >

7 Dividend Stocks to Buy at a 52-Week Low ↗

February 12, 2024

Each of these dividend stocks has been down sharply in the last 12 months but has fundamental reasons that support a turnaround.

Via InvestorPlace

Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period

February 12, 2024

From Bristol Myers Squibb

Via Business Wire

Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb ↗

February 09, 2024

Via Benzinga

Bernie Sanders Blasts Big Pharma's Pricing Of Lifesaving Drugs In US During Senate Hearing On Medicare ↗

February 09, 2024

Via Benzinga

7 Biotech Stocks Fighting America’s Deadliest Diseases ↗

February 08, 2024

Although the human condition can be alarmingly frail at times, these groundbreaking biotech stocks are aiming to right the ship.

Via InvestorPlace

Bristol-Myers Squibb Options Trading: A Deep Dive into Market Sentiment ↗

February 05, 2024

Via Benzinga

Bristol-Myers Squibb's Earnings Outlook ↗

February 01, 2024

Via Benzinga

How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month ↗

February 08, 2024

Cytokinetics is looking to take on Bristol Myers Squibb in treating a heart disease.

Via Investor's Business Daily

3 Blue-Chip Stocks to Buy at a 52-Week Low in February ↗

February 07, 2024

Higher-for-longer interest rates and undervalued metrics make it a good time to look for blue-chip stocks at a low price.

Via InvestorPlace

Pancreatic Cancer Treatments Poised for Major Advances in 2024

February 07, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:INCY),(NASDAQ:TNGX),(NASDAQ:RYZB),(NYSE:BMY) EQNX::TICKER_END

Via FinancialNewsMedia

Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo in Resectable Non-Small Cell Lung Cancer

February 07, 2024

From Bristol Myers Squibb

Via Business Wire

UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst ↗

February 06, 2024

UBS bullish on Axsome's Auvelity launch and pipeline, foreseeing $1 billion sales by 2030. Buy rating, $111 price target. Positive Phase 3 data for Alzheimer's Agitation and Narcolepsy.

Via Benzinga

Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

February 06, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Catalent, Inc. (NYSE – CTLT), Everbridge, Inc. (Nasdaq – EVBG), Slam Corp. (Nasdaq – SLAM), Karuna Therapeutics, Inc. (Nasdaq – KRTX)

February 05, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Bristol Myers Squibb Named One of America’s Most JUST Companies by JUST Capital and CNBC

February 05, 2024

From Bristol Myers Squibb

Via Business Wire

Undervalued Gems: 7 Stocks Set for a Major Rebound ↗

February 05, 2024

Each of these seven undervalued stocks has fallen by 25% or more from its 52-week high, but may have a path back to prior prices.

Via InvestorPlace

Bristol Myers Squibb and 2seventy bio Share Update on U.S. FDA Oncologic Drugs Advisory Committee Meeting for Abecma in Triple-Class Exposed Multiple Myeloma Based on KarMMa-3 Study

February 05, 2024

From Bristol Myers Squibb

Via Business Wire

3 Blue Chip Dividend Stocks To Play Defense ↗

February 02, 2024

We will discuss 3 long-term blue chip stocks to play defense. They have raised their dividends each year for over ten years, have current yields above the S&P 500 Index average, and should continue to...

Via Talk Markets

Topics Stocks

Bristol Myers Squibb (BMY) Q4 2023 Earnings Call Transcript ↗

February 02, 2024

BMY earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations ↗

February 02, 2024

The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.

Via Benzinga

Topics Economy

Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review ↗

February 02, 2024

The Dow led the major indexes higher. Big techs diverged on results.

Via Investor's Business Daily

Topics Economy Stocks

What's Going On With US Pharma Giant Bristol-Myers Squibb Stock Today? ↗

February 02, 2024

Bristol Myers Squibb reports Q4 revenues of $11.48 billion, up 1% YoY. Eliquis and Opdivo sales drive growth, offsetting Revlimid decline.

Via Benzinga

Bristol Myers Shares Rise On Fourth-Quarter Earnings Beat ↗

February 02, 2024

Bristol Myers earnings came in above expectations, although Opdivo sales were slower than expected. BMY stock gained.

Via Investor's Business Daily

Nasdaq Futures Climb As Meta, Amazon Gains Offset Apple Slide: Analyst Points to 2 Factors Reinforcing Bullish Outlook This Year ↗

February 02, 2024

Stock futures are pointing upwards on Friday as traders assess earnings reports from Meta Platforms, Inc.

Via Benzinga

Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023

February 02, 2024

From Bristol Myers Squibb

Via Business Wire

Earnings Scheduled For February 2, 2024 ↗

February 02, 2024

Companies Reporting Before The Bell • W.W. Grainger (NYSE:GWW) is likely to report quarterly earnings at $8.05 per share on revenue of $4.04 billion.

Via Benzinga

Investor Optimism Improves Following Earnings, Economic Reports; Dow Jumps Over 350 Points ↗

February 02, 2024

The CNN Money Fear and Greed index showed an increase in the overall market sentiment, but the index remained in the "Greed" zone on Thursday.

Via Benzinga

Topics Stocks

Amazon, Apple And 3 Stocks To Watch Heading Into Friday ↗

February 02, 2024

With U.S. stock futures trading mostly higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

BMY Stock Dividend Delight: A Blue-Chip’s Healthy Yield ↗

January 31, 2024

In the grand theater of the financial markets, Bristol-Myers Squibb stands out as a robust performer. Despite the recent pullback, the market sentiment towards this biopharmaceutical titan remains...

Via Talk Markets

Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60% ↗

January 30, 2024

Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions.

Via Benzinga

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

83 84 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.